LA JOLLA PHARMACEUTICAL

la-jolla-pharmaceutical-logo

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. LJPC-501, the Company's second product candidate, is a natural peptide for the treatment of the hepatorenal syndrome.

#SimilarOrganizations #People #Financial #Event #Website #More

LA JOLLA PHARMACEUTICAL

Industry:
Biopharma Biotechnology Therapeutics

Founded:
1989-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.lajollapharmaceutical.com

Total Employee:
101+

Status:
Active

Contact:
(858)207-4264

Email Addresses:
[email protected]

Total Funding:
190.94 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Amazon GStatic Google Static Content Amazon Virginia Region Sectigo SSL


Similar Organizations

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.


Current Advisors List

not_available_image

Tariq Sethi Scientific Advisors @ La jolla Pharmaceutical
Advisor

not_available_image

Fu-Tong Liu Scientific Advisors @ La jolla Pharmaceutical
Advisor

Current Employees Featured

not_available_image

Saiid Zarrabian
Saiid Zarrabian Director and Chairman of the Board @ La jolla Pharmaceutical
Director and Chairman of the Board

george-f-tidmarsh_image

George F. Tidmarsh
George F. Tidmarsh President, Chief Executive Officer and Secretary, Board of Directors @ La jolla Pharmaceutical
President, Chief Executive Officer and Secretary, Board of Directors

not_available_image

Michael Hearne
Michael Hearne Chief Financial Officer @ La jolla Pharmaceutical
Chief Financial Officer
2020-01-01

laura-l-douglass_image

Laura L. Douglass
Laura L. Douglass Director @ La jolla Pharmaceutical
Director

larry-edwards_image

Larry Edwards
Larry Edwards President and CEO @ La jolla Pharmaceutical
President and CEO
2021-01-01

not_available_image

Stacey Ruiz
Stacey Ruiz Director of Research and Development @ La jolla Pharmaceutical
Director of Research and Development

craig-johnson_image

Craig Johnson
Craig Johnson Director @ La jolla Pharmaceutical
Director

Stock Details


Company's stock symbol is NASDAQ:LJPC

Acquisitions List

Date Company Article Price
2020-07-28 Tetraphase Pharmaceuticals Tetraphase Pharmaceuticals acquired by La jolla Pharmaceutical N/A

Official Site Inspections

http://www.lajollapharmaceutical.com Semrush global rank: 4.51 M Semrush visits lastest month: 2.36 K

  • Host name: server-3-162-103-58.iad61.r.cloudfront.net
  • IP address: 3.162.103.58
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "La jolla Pharmaceutical"

La jolla Pharmaceutical - Crunchbase Company Profile โ€ฆ

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics โ€ฆSee details»

La Jolla Pharmaceutical - Org Chart, Teams, Culture

La Jolla Pharmaceutical. 0 followers. Join to edit. La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to โ€ฆSee details»

La Jolla Pharmaceutical - Overview, News & Similar companies

Oct 14, 2022 Who is La Jolla Pharmaceutical. La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization โ€ฆSee details»

La Jolla Pharmaceutical Company Company Overview, Contact โ€ฆ

Learn more about La Jolla Pharmaceutical Company's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today. ...See details»

La Jolla Pharmaceutical Company - Dun & Bradstreet

Company Description: La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening โ€ฆSee details»

La Jolla Pharmaceutical - VentureRadar

La Jolla Pharmaceutical VentureRadar profile. Find out more about La Jolla Pharmaceutical, Small Molecules and Biologics.See details»

La Jolla Pharmaceutical Company - SignalHire

Organization Website: lajollapharmaceutical.com : Phone Number: 617-715-3600: La Jolla Pharmaceuti... industries Biotech: Headquarters Location: 201 Jones Rd, Suite 400, Waltham, โ€ฆSee details»

La Jolla Pharmaceutical Co.

Explore La Jolla Pharmaceutical Co. with its drug pipeline, therapeutic area, technology platform, 47 clinical trials, 71 news, and 99 literature, Disease Domain:Hemic and Lymphatic Diseases, โ€ฆSee details»

La Jolla Pharmaceutical Company - LinkedIn

La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life โ€ฆSee details»

La Jolla Pharmaceutical Company Profile | Management and

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. ... SQL โ€ฆSee details»

M&A Summary, Ownership, and Business Overview - Mergr

La Jolla Pharmaceutical has acquired 2 companies of its own, including 1 in the last 5 years. La Jolla Pharmaceuticalโ€™s largest acquisition to date was in 2020, when it acquired Tetraphase โ€ฆSee details»

La Jolla Pharmaceutical - 2025 Company Profile - Tracxn

Mar 23, 2025 La Jolla Pharmaceutical is developing therapies for treating life-threatening diseases. The company's lead product candidate, LJPC-401 is its a formulation of synthetic โ€ฆSee details»

LA JOLLA PHARMACEUTICAL COMPANY - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for LA JOLLA PHARMACEUTICAL COMPANY of San Diego, CA. Get the latest business insights from Dun โ€ฆSee details»

LA JOLLA PHARMACEUTICAL Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for LA JOLLA PHARMACEUTICAL of San Diego, CA. Get the latest business insights from Dun & โ€ฆSee details»

La Jolla Pharmaceutical Company - Products, Competitors, โ€ฆ

La Jolla Pharmaceutical (NASDAQ: LJPC) is a biopharmaceutical firm engaged in the discovery, development and commercialization of therapies intended to significantly improve outcomes in โ€ฆSee details»

La Jolla Pharmaceutical Co. | Key People and Executives

Jul 8, 2019 La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to โ€ฆSee details»

La Jolla Pharmaceutical Company Company Profile & Data: stocks, โ€ฆ

Aug 1, 2022 La Jolla Pharmaceutical Company market capitalization over time ... It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. โ€ฆSee details»

La Jolla Pharmaceutical Company - Craft

Aug 22, 2022 La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ โ€ฆSee details»

La Jolla Pharmaceutical Company Company Profile - Overview

La Jolla Pharmaceutical Company is developing drugs for the treatment of complicated intra-abdominal infections and skin and skin structure infections caused by bacteria. The company โ€ฆSee details»

35-YEAR INDUSTRY-ACADEMIC PARTNERSHIP YIELDING โ€ฆ

23 hours ago A 35-year academic-industry partnership that has produced groundbreaking discoveries in immunology and supported first-in-class therapies for rare disease patients has โ€ฆSee details»

linkstock.net © 2022. All rights reserved